Brought to you by 
Proteus Biomedical brings in $25.5mm through late-stage round
21 Apr 2021
Executive Summary
Cardio, metabolic, and CNS disorders-focused Proteus Biomedical (micro-electromechanical systems) has raised $25.5mm through the sale of shares to nine investors in a late-stage venture round. According to the company's Form D, it could bring in another $9.5mm. Proteus's first product is a sensor-based device used for cardiac resynchronization therapy in treating congestive heart failure.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Monitoring Equipment & Devices
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Proteus Biomedical brings in $25.5mm through late-stage round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice